IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Memorial Sloan Kettering Cancer Center
Institut Bergonié
Beth Israel Deaconess Medical Center
National Institutes of Health Clinical Center (CC)
European Organisation for Research and Treatment of Cancer - EORTC
Mayo Clinic
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Washington
Universitaire Ziekenhuizen KU Leuven
National Cancer Institute (NCI)
UMC Utrecht
Case Comprehensive Cancer Center
Fox Chase Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris